0000920465-19-000149.txt : 20191024 0000920465-19-000149.hdr.sgml : 20191024 20191024200351 ACCESSION NUMBER: 0000920465-19-000149 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191022 FILED AS OF DATE: 20191024 DATE AS OF CHANGE: 20191024 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RAMSAY DAVID A CENTRAL INDEX KEY: 0001283292 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 191167185 MAIL ADDRESS: STREET 1: HALOZYME THERAPEUTICS, INC. STREET 2: 11588 SORRENTO VALLEY ROAD, #17 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 wf-form4_157196180453149.xml FORM 4 X0306 4 2019-10-22 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001283292 RAMSAY DAVID A C/O LA JOLLA PHARMACEUTICAL COMPANY 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 1 0 0 0 Stock Option (Right to Buy) 8.43 2019-10-22 4 A 0 18000 0 A 2029-10-22 Common Stock 18000.0 18000 D This option vests and becomes exercisable over three years from the date of grant. /s/ Ryan Murr, by power of attorney for David A. Ramsay 2019-10-24